Ginger enhances antioxidant activity and attenuates atherogenesis in diabetic cholesterol-fed rats

Australian Journal of Basic and Applied Sciences

Volumn 5, Issue 12, 2011, Pages 2150-2158

  Al Azhary, Diaa B ^a  

^a Minia University ^*  (Egypt)

Author keywords

Antioxidants; Diabetes; Ginger; Lipid peroxidation; Vascular disorders

Indexed keywords

EID: 84856497446     PISSN: 19918178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Adhikari, S., K. Priyadarsini and T. Mukherjee, 2007. Physico-chemical studies on the evaluation of the antioxidant activity of herbal extracts and active principles of some indian medicinal plants. J. Clin. Biochem. Nutr., 40(3): 174-183.
2. Ahmed, R., V. Seth and B. Banerjee, 2000. Influence of dietary ginger (Zingiber officinales Rosc) on antioxidant defense system in rat: comparison with ascorbic acid. Indian J. Exp. Biol., 38: 604-606.
3. Al-Amin, Z., M. Thomson, K. Al-qattan, R. Peltonen-Shalaby and M. Ali, 2006. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br. J. Nutr., 96(4): 660-666.
4. Al-Benna, S., C. Hamilton, J. McClure, P. Rogers, G. Berg, I. Ford, C. Delles and A. Dominiczak, 2006. Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins From patients with coronary artery disease. Arterioscl. Thromb.Vascul. Biol., 26: 218-223.
5. Ali, B., G. Blunden, M. Tanira and A. Nemmar, 2008. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem. Toxicol., 46: 409-420.
6. Allain, C., L. Poon, C. Chan, W. Richmond and P. Fu, 1974. Enzymatic determination of total serum cholesterol. Clin. Chem., 20: 470-475.
7. Assmann, G., H. Schulte, H. Funke and von A. Eckardstein, 1998. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur. Heart J, 19 (Suppl M): 8-14.
8. Beutler, E., O. Duron and B. Kefly, 1963. Improved method for the determination of blood glutathione. J. Lab. Clin. Med., 61: 882-888.
9. Bordia, A., S. Verma and K. Srivastava, 1997. Effects of ginger and fenugreek on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins, Leukotrienes and essential fatty acids, 56: 379-384.
10. Cao, Z., Z. Chen and P. Guo, 1993. Scavenging effect of ginger on superoxide anion and hydroxyl radical. Chung - kuo Chung Yao Tsa Chih, 18: 750-764.
11. Cederberg, J., S. Basu and U. Eriksson, 2001. Increased rate of lipid peroxidation and protein carbonylation oxidative stress, Exercise and Diabetes in experimental diabetic pregnancy. Diabetologia, 44: 766-774.
12. Ceriello, A. and E. Motz, 2004. Is oxidative stress the pathogenic mechanism underlying insulin resistence, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arteriosc. Thromb.Vasc. Biol., 24: 816-823.
13. Chrubasik, S., M. Pittler and B. Routfogalis, 2004. Zingiberis rhizome: A comprehensive review on the ginger effect and efficacy profiles. Phytomedicine, 12(9): 684-701.
14. Dominic, S., G. Maguire, J. Wylie, A. Ravandi, W. Xuan, Z. Ahmed, M. Eskandarian, A. Kuksis and P. Connelly, 2002. Oxidative Stress Is Markedly Elevated in Lecithin:Cholesterol Acyltransferase-deficient Mice and Is Paradoxically Reversed in the Apolipoprotein E Knockout Background in Association with a Reduction in Atherosclerosis. J. Biol. Chem., 277(14): 11715-11720.
15. Evagelos, N., S. Stella and P. Dimitri, 2005. Management of High Triglycerides: What Non-Specialists in Lipids Need to Know. Hell J. Cardiol., 46: 268-272.
16. Fassati, P. and L. Prencipe, 1982. Serum triglycerides determined colormrtrically with an enzyme that produces hydrogenperoxide. Clin. Chem., 28(10): 2077-2080
17. Fhrman, B., M. Rosenblat, T. Hoyek., R. Coleman and M. Aviram, 2000. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherasclerasis in atherosclerotic, apolipoprotein E-deficient mice. J. Nutrition, 130: 1124-1131.
18. Garcia-Frade, L., H. Calle, I. Alava, J. Navarro, L. Creighton and P. Gaffeny, 1987. Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage. Thromb. Res., 47(5): 533-540.
19. Ghasemzadeh, A., H. Jaafar and A. Rahmat, 2010. Antioxidant activities, total phenolics and flavonoids content in two varieties of Malaysia young ginger (Zingiber officinale Roscoe). Molecules, 15(6): 4324-4333.
20. Ghayur, M., A. Gilani, M. Afridi, and P. Houghton, 2005. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascular pharmacology, 43(4): 234-241.
21. Hannon-Fletcher, M., M. O'Kane, K. Moles, C. Weatherup, C. Barnett and Y. Barnett, 2000. Levels of peripheral blood cell DNA damage in insulin dependent diabetes mellitus human subject. Mutat. Res., 460: 53-60.
22. Hokanson, J. and M. Austin, 1996. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of populationbased prospective studies. J. Cardiovasc. Risk., 3: 213-219.
23. Keaney, J., J. Gaziano A. Xu, B. Frei, J. Curran-Cellentano, G. Shwaery, J. Loscalzo and J. Vita, 1993. Dietary antioxidants preserve endothelium dependent vessel relaxation in cholesterol-fed rabbits. Proc. Nath. Acad. Sci., 90: 11880-11884.
24. Khaki, A. and A. Khaki, 2010. Antioxidant effect of ginger to prevents lead-induced liver tissue apoptosis in rat. Journal of Medicinal Plants Research, 4(14): 1492-1495.
25. Koracevic, D., G. Koracevic, V. Djordjevic, S. Andrejevic and V. Cosic, 2001. Method for the measurement of antioxidant activity in human fluids. J. Clin. Pathol., 54: 356-361.
26. Krishnakantha, T. and B. Lokesh, 1993. Scavenging of superoxide anions by spice principles. Indian J. Biochem. Biophys., 30: 133-134.
27. Laakso, M., 1995. Epidemiology of diabetic dyslipidemia. Diabetic Review, 3: 408-422.
28. Langner, E., S. Greifenberg and J. Gruenwald, 1998. Ginger: history and use. Adv. Ther., 15(1): 25-44.
29. Lee, C., J. Choi, D. Pak, D. Kang, T. Register and M. Adams, 1999. Inhibition of expression of P-selectin by antioxidant in cholesterol-fed rats. J. Korean Med. Sci., 14: 8-14.
30. Lee, E. and Y. Surh, 1998. Induction of apoptosis in HL-60 cells by pungent vaniloids, -gingerol and - paradol. Cancer Lett., 134(2): 163-168.
31. Lopez-Virella, M., P. Stone, S. Ellis and J. Coltwell, 1977. Cholesterol determination in high density lipoproteins separated by three different methods. Clin. Chem., 23: 882-884.
32. Masuda, J. and R. Ross, 1990. Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak convertion to fibrous plaque. Arterioscl., 10:178-187.
33. Nakagami, H., Y. Kaneda, T. Ogihara and R. Morishita, 2005. Endothelial dysfunction in hyperglycemia as a trigger of atherosclerosis. Curr. Diabetes Rev., 1(1): 59-63.
34. Nilsson, J., 1986. Growth factors and the pathogenesis of atherosclerosis. Atherosclerosis, 62: 185-199.
35. Nogueira de Melo, G., R. Grespan, J. Fonseca, T. Farinha, E. Leite da Silva, and A. Romero, 2011. Inhibitory effects of ginger (Zingiber officinale Roscoe) essential oil on leukocyte migration in vivo and in vitro. J. Nat. Med., 65: 241-246.
36. Nordestgard, B.G. and D.B. Zilversmit, 1989. Comparison arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits differences in intimal clearance explained by size differences. Arteriosclerosis, 9: 176-183.
37. Pappolla, M., M. Smith, T. Bryant-Thomas, N. Bazan, S. Petanceska, G. Perry, L. Thal, M. Sano, and L. Refolo, 2002. Cholesterol, oxidative stress, and Alzheimer's disease: expanding the horizons of pathogenesis. Free Radical Biology and Medicine, 33(9): 173-181.
38. Ramakrishna, V. and R. Jailkhani, 2007. Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. Diagnostic Pathology, 2: 22.
39. Ridker, P., 2008. Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: Do we need to revisit the oral triglyceride tolerance test? Clinical Chemistry, 54: 11-13.
40. Ross, R., 1981. Atherosclerosis: a problem of the biology of arterial wall cells and their interactionswih blood components. Arteriosclerosis, 1: 293-311.
41. Ryu, J., G. Howard, T. Craven, M. Bond, A. Hagaman, and J. Crouse, 1992. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke, 23: 823-828.
42. Satoh, K., 1978. Plasma lipid peroxide in cerebrovascular disorder determined by a new colorimetric method. Clinica. Chimica. Acta, 90: 37-43.
43. Schaefer, E., A. Lichtenstein, S. Lamon-Fava, J. McNamara, and J. Ordovas, 1995. Lipoprotein, nutrition, aging and atherosclerosis. Am. J. Clin. Nutr., 61(suppl.): 726-740.
44. Sengenes, C., A. Miranville, K. Lolmede, C. Curat, and A. Bouloumie, 2007. The role of endothelial cells in inflamed adipose tissue. J. Intern. Med., 262: 415-42.
45. Shen, C., K. Hong, and S. Kim, 2005. Comparative effects of ginger root (Zingiber officinale Rosc.) on the production of inflammatory mediators in normal and osteoarthrotic sow chondrocytes. Journal of medicinal food, 8(2): 149-153.
46. +-ATPase and Helicobacter pylori growth by phenolic antioxidants of Zingiber officinale. Mol. Nutr. Food Res., 51(3): 324-332.
47. Siti-Balkis, B., O. Khairul, W. Wan Nazaimoon, O. Faizah, R. Santhana, A. Mokhtar, R. Megat and M. Jamaludin, 2008. Alpha lipoic acid reduces plasma glucose and lipid and the ultra-microscopic vascular changes in streptozotocin-induced diabetic rats. Annals of Microscopy, 8: 58.
48. Stout, R.W., 1979. Diabetes and atherosclerosis - the role of insulin. Diabetologia, 16: 141-150.
49. Taskinen, M.R, T. Kuusi, E. Helve, E.A. Nikkila and H. Yki-Järvinen, 1988. Insulin therapy induces antiatherogenic changes of serum lipoproteins in non-insulin-dependent diabetes. Arteriosclerosis, 8: 168-177.
50. Thomson, M., K. Al Qattan, S. Al Sawan, M. Alnaqeeb, I. Khan and M. Ali, 2002. The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent. Prostaglandins Leukot. Essent. Fatty Acids, 67(6):475-478.
51. Trinder, P., 1969. Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor. Ann. Clin. Biochem., 6: 24-25.
52. Verma, S., M. Singh, P. Jain, and A. Bordia, 2004. Protective effect of ginger, Zingber officinale ROSC on experimental atherosclerosis in rabbits. Indian J. Exp. Biol., 42(7): 736-738.
53. Weidner, M. and K. Sigwart, 2000. The safety of a ginger extract in the rat. J. Ethanopharmacol., 73(3): 513-520.
54. Wieland, H. and D. Seidel, 1983. A simple specific method for precipitation of low density lipoproteins. J. Lipid Res., 24: 904-909.
55. Zick, S., Z. Djuric, M. Ruffin, A. Litzinger, D. Normolle, S. Alrawi, M. Feng and D. Brenner, 2008. Pharmacokinetics of 6-Gingerol, 8-Gingerol, 10-Gingerol, and 6-Shogaol and Conjugate Metabolites in Healthy Human Subjects. Cancer Epidemiol. Biomarkers Prev., 17(8):1930-1936.